Frequency of >2%: Headache, diarrhea, nausea, abdominal pain, vomiting, flatulence, dizziness, arthralgia.
Frequency of <2%:
Body as a Whole: allergic reaction, fever, photosensitivity reaction, facial edema, thrombophlebitis (I.V. only).
Gastrointestinal: Constipation, dry mouth, hepatitis hematologic, leukopenia (reported in ex-US clinical trials only), thrombocytopenia.
Metabolic/Nutritional: Elevated CPK (creatinine phosphokinase), generalized edema, elevated triglycerides, liver function tests abnormal.
Musculoskeletal: Myalgia.
Nervous: Depression, vertigo.
Skin and Appendages: Urticarial, rash, pruritus.
Special Senses: Blurred vision.
Post Marketing Experience: General Disorders and Administration Conditions: asthenia, fatigue, malaise.
Immune System Disorders: anaphylaxis (including anaphylactic shock).
Investigations: weight changes.
Skin and Subcutaneous Tissue Disorders: severe dermatologic reactions (some fatal), including erythema multiforme. Steven-Johnson syndrome, and toxic epidermal necrolysis (TEN), and angioedema (Quincke's edema).
Musculoskeletal Disorders: rhabdomyolysis, bone fracture.
Renal and Urinary Disorders: interstitial nephritis.
Hepatobiliary Disorders: hepatocellular damage leading to jaundice and hepatic failure.
Psychiatric Disorder: hallucinations, confusions, insomnia, somnolence.
Metabolism and Nutritional Disorders: hyponatremia, hypomagnesemia.
Infections and infestations: Clostridium difficile associated diarrhea.
Hematologic: pancytopenia, agranulocytosis.
Nervous: ageusia, dysgeusia.